Background: A key feature of the inflammatory response after cerebral ischemia is the brain infiltration of blood monocytes. There are two main monocyte subsets in the mouse blood: CCR2 + Ly6C hi "inflammatory" monocytes involved in acute inflammation, and CX3CR1 + Ly6C lo "patrolling" monocytes, which may play a role in repair processes. We hypothesized that CCR2
Background
Activation of brain-resident cells and mobilization of circulating leukocytes is a key feature of the inflammatory response after cerebral ischemia [1] . In animal models as in human stroke, post-ischemic brain inflammation is characterized by infiltration of hematogenous immune cells, monocyte-derived tissue macrophages (Mo/MΦ) being one of the predominant cell types [2] [3] [4] [5] . Growing evidence suggests that Mo/MΦ invading the ischemic brain can contribute to both brain injury [6, 7] and repair [8, 9] . These opposing roles reflect the heterogeneity of the monocyte-macrophage lineage, which may adopt diverse phenotypes depending on environmental cues [10] .
Two predominant subsets of circulating monocytes (CD115+ leukocytes) are found in the blood of rodents and humans: "inflammatory " and "patrolling" monocytes. In mice, inflammatory monocytes are characterized by the expression of the C-C chemokine receptor type 2 (CCR2), a critical molecule involved in the rapid recruitment of the cells into inflamed tissues [11] . They also express high levels of lymphocyte antigen 6 complex locus C1 (Ly6C) but low to intermediate levels of C-X(3)-C motif chemokine receptor 1 (CX3CR1). On the other hand, CX3CR1, the high-affinity functional chemokine receptor for fractalkine (CX3CL1), is enriched in patrolling monocytes, which do not express Ly6C and CCR2 or express them at low levels. Patrolling monocytes (Ly6C   lo   CCR2 − CX3CR1 + ) have longer half-life and crawl on the vessel luminal wall orchestrating the disposal of damaged endothelial cells [12] . In addition, patrolling monocytes can rapidly invade tissues in response to tissue damage or infection [13, 14] . Patrolling monocytes were previously thought to originate from circulating inflammatory CD115 + Ly6C hi monocytes [14, 15] , but recent data suggest that they originate from distinct myeloid progenitors by the activity of the nuclear receptor subfamily 4, group A, member 1 transcription factor NR4A1 (Nur77) in the BM [16] . Furthermore, depletion of CD115 + Ly6C hi monocytes in the circulation does not affect the numbers of CD115 + Ly6C lo monocytes, reducing the likelihood that the sole precursors of "patrolling" monocytes are CD115 + Ly6C hi cells [17] . Little is known about the monocytes subtypes invading the ischemic brain, their morphology, and their fate once in the tissue. Monocytes infiltrating the ischemic brain acquire morphological and functional properties of tissue macrophages and can persist in the brain parenchyma for extended periods of time [7, 8, [18] [19] [20] . However, the trafficking of inflammatory and patrolling monocytes into the ischemic brain, their relationship to the development of tissue injury, and their long-term fate remain unknown.
Here, we investigated the temporal profile, spatial distribution, and phenotype of inflammatory (CCR2 hi monocytes as the primary monocytic cell infiltrating the ischemic brain, where they undergo phenotypic transformation during the evolution of the damage. Such phenotypic diversity may underlie the multiplicity of roles attributed to Mo/MΦ in ischemic brain injury.
Methods

Mice
Experiments were performed in 8-12-week-old male CCR2
, or NR4A1 −/− on a C57Bl/6J genetic background. Age-matched wild-type (WT) mice (C57Bl/6J, Jackson Laboratory, Bar Harbor, ME) served as controls. All animal experiments were performed in accordance with the ARRIVE guidelines [21] .
Middle cerebral artery occlusion
Transient focal cerebral ischemia was induced using the intraluminal filament model of middle cerebral artery occlusion (MCAo), as described previously [22] . Under isoflurane anesthesia (maintenance 1.5-2 %), a heatblunted nylon suture (6/0) was inserted into the right external carotid artery of anesthetized mice and advanced until it obstructed the middle cerebral artery (MCA). This was confirmed by cerebral blood flow (CBF) measured using transcranial laser Doppler flowmetry (Periflux System 5010, Perimed, King Park, NY) in the territory of the right MCA (2 mm posterior, 5 mm lateral to bregma). The filament was left in place for 35 min and then withdrawn. Only animals that exhibited a reduction in CBF of >85 % during MCA occlusion and in which CBF recovered by >80 % after 10 min of reperfusion were included in the study. Inadequate ischemia-reperfusion was found to be <4 % in the study and not different among groups. Rectal temperature was monitored and kept constant (37.0 ± 0.5°C) during the surgical procedure and in the recovery period until the animals regained full consciousness. No differences were found in mortality rate (<1 %) among groups.
Bone marrow CCR2
RFP/+
CX3CR1
GFP/+ and NR4A1 −/− chimera generation CCR2 RFP/RFP (JAX 017586) and CX3CR1 GFP/GFP (JAX 005582) mice were crossed to obtain heterozygous mice that underwent chromosome recombination between the CCR2 and CX3CR1 loci (CCR2 RFP/+ CX3CR1 GFP/+ mice). Recombination of CCR2 and CX3CR1 loci was confirmed by polymerase chain reaction (PCR) using tail DNA. DNA was purified from tails using NaOH extraction [23] . Target primer sequences were CX3CR1_for 5′-TCTG  CTGAGGCCTGTTATTTG-3′ and CX3CR1_rev 5′-ACC  AGACCGAACGTGAAGAC-3′; enhanced green fluorescent protein (EGFP)_for 5′-ctgaccctgaagttcatctgc-3′ and  EGFP_rev 5′-gcttgtcggccatgatataga-3′; CCR2_for 5′-GGAT  TAAGGAATTTGGCATTTG-3′, CCR2_rev 5′-GGAGTA  GAGTGGAGGCAGGA-3′, and red mice. Donor BM cells were flushed out with 2-3 ml of phosphate-buffered saline (PBS) from the femur and tibias, filtered through a 40-μm nylon mesh and counted for viability before injection. Transplanted mice were housed in cages with sulfatrim pellets for the first 2 weeks after irradiation. The restricted expression of green fluorescent protein (GFP) in hematogenous CX3CR1 cells allows for differentiation of infiltrating CX3CR1 GFP/+ monocytes from central nervous system (CNS)-resident CX3CR1 + microglia. In a distinct group of WT mice, irradiation with head protection was performed using a custom designed lead shield (2.5 cm thickness) under the aforementioned irradiation procedure. For NR4A1 −/− chimera generation, WT mice were lethally irradiated as described above, and donor BM from NR4A1 −/− mice (JAX 006187) was used to produce WT mice with NR4A1-null leukocytes. Deletion of NR4A1 in blood leukocytes was analyzed in the chimeric mice by determining the absence of Ly6C Mice were perfused transcardially with ice-cold PBS followed by 4 % paraformaldehyde in PBS. Brains were removed, stored overnight in the same fixative at 4°C, and then submerged in 30 % sucrose solution for 2 days and frozen. Using a cryostat, 12 serial coronal sections (thickness 16 μm) were cut every 600 μm from the frontal cortex to the caudal hippocampus (+3.14 to −3.46 bregma) and then mounted on slides (Fig. 1b) . Fluorescent images were acquired by a scientific monochrome CCD camera (Retiga EXi, QImaging) using fluorescein isothiocyanate (FITC) (CX3CR1-GFP) and Texas Red (CCR2-RFP) filter sets through a 10× objective on a Nikon TE2000 microscope equipped with a motorized stage. Acquisition was controlled via software (IPLab, Biovision Technologies, Exton, PA) using a custom script. Individual image files (80 for each hemisphere) were combined using the ImageJ software (National Institute of Health, version 1.45) by invoking a stitching algorithm [24] . A custom ImageJ macro was used to semi-automatically count cells identified after thresholding the image based on pixel values. In lesions at 14 and 28 days after ischemia, we observed a densely populated lesion core where individual cells could not be unequivocally separated from neighboring cells. Therefore, these areas were excluded from the analysis. For presentation purposes, binary image masks of both green and red channel images generated for cell counting were superimposed on a grayscale image obtained from the FITC channel image by running the ImageJ "Remove Outliers" command once and the ImageJ "Smooth" command twice.
Immunofluorescence GFP/+ cells was quantified within the ischemic hemisphere in images acquired with a 40× objective from 1.3, 0.7, −0.1, −0.5, and −1.1 bregma coronal brain sections at 14 days post-MCAO that were stained for GLUT-1 using ImageJ software. For the analysis of Ki67 + cells, coronal sections were scanned with a confocal microscope and Ki67 + and CX3CR1 GFP/+ cells were quantified from tile-scanned images using ImageJ software.
Brain mononuclear cell isolation
Mice were transcardially perfused under deep anesthesia with 30 ml of heparinized saline to remove blood cells. The ischemic hemisphere was separated from the cerebellum and olfactory bulb and homogenized with a dounce homogenizer in RPMI Medium 1640 with Phenol Red. Then, the cell suspension was subjected to discontinuous 70 %/25 % Percoll (GE Healthcare, Piscataway, NJ) density gradient centrifugation (30 min, 500 g, 4°C). Enrichedmononuclear cells were collected from the interphase, washed with Hepes-HBSS buffer (138 mM NaCl, 5 mM KCl, 0.4 mM Na 2 HPO 4 , 0.4 mM KH 2 PO 4 , 5 mM D-Glucose, 10 mM Hepes, pH 7.4), and resuspended in 2 % fetal bovine serum (FBS) in PBS FACS buffer for staining and FACS analysis.
Flow cytometry and cell sorting
Rat monoclonal antibodies used for flow cytometry analysis include CD45-BV 510 or CD45-APC (clone 30 F-11), Ly6C-FITC (clone HK1.4), CX3CR1-PE (clone SA011F11), Ly6G-PerCP-Cy5.5 (clone 1A8), CD8a-PerCP-Cy5.5 (clone 53-6.7), CD115-PE (clone AFS98), NK1.1-APC (clone PK136), and CD11b-APC-Cy7 (clone M1/70) from BioLegend (San Diego, California) and CCR2-APC (clone 475301) from R&D. For flow cytometric analysis of blood leukocytes, 100 μl of blood was withdrawn by cardiac puncture from mice under deep anesthesia immediately before sacrifice. Erythrocytes were lysed by incubating the blood three times with 5 ml erythrocyte lysis buffer (0.15 M NH 4 Cl, 1 mM KH 2 CO 3 , and 0.1 mM Na-EDTA) for 5 min at room temperature. Blood leukocytes were resuspended in FACS buffer. Cells were blocked with CD16/CD32 antibody for 10 min at 4°C, stained with predetermined optimal concentrations of antibodies for 20 min at 4°C, and analyzed on a MACSQuant (Miltenyi Biotec) or a FACSCalibur (Becton-Dickinson) cytometer. Dead cells and debris were excluded based on side and forward scatter profiles (SSC and FSC, respectively). Appropriate isotype control antibodies, "fluorescence minus one" staining and staining of negative populations were used to establish compensation parameters and sorting gates. Absolute cell numbers and frequencies were recorded. Data were analyzed using FlowJo software (FlowJo, Ashland, OR).
Data analysis
Data are expressed as mean ± SE. Intergroup differences were analyzed using a Student unpaired t test or one-way ANOVA, as appropriate. Differences were considered statistically significant for p < 0.05. Animals were randomly assigned to treatment and control groups and analysis was performed in a blinded fashion.
Results
CCR2
+ Mo/MΦ accumulate in the ischemic brain before
To investigate brain trafficking of monocytes after cerebral ischemia, we generated CX3CR1 
RFP/+ chimeras that underwent MCAo revealed a significant infiltration of monocytes in the ischemic brain (Fig. 1) . CCR2
RFP/+ cells rapidly increased in the ischemic hemisphere 3 days after MCAo, evenly infiltrating the injured tissue, identified by Nissl stain of adjacent brain sections, with minimal penetration of the healthy tissue (Fig. 1a) . During the subacute and chronic phase of injury (day 14-28 after MCAo), CCR2
RFP/+ cells were confined to the lesion core and their number decreased elsewhere (Fig. 1a) . The number of CCR2 RFP/+ cells was highly dense in the lesion core 14-28 days after ischemia, which made it impossible to differentiate single cells, and therefore, this region was excluded for the quantitative analysis (see the "Methods" section; Fig. 1b) . CX3CR1 GFP/+ cell numbers increased moderately in the first 7 days after MCAo and peaked at 14-28 days post-ischemia (Fig. 1a-b) . CX3CR1
GFP/+ cells delimited the CCR2 RFP/+ cell-laden core at 14 days after MCAo and were also found, albeit sparsely, throughout the entire lesion. This anatomical distribution remained unmodified 28 days after MCAo (Fig. 1a) . In brains of mice undergoing sham surgery, CCR2
RFP/+ and CX3CR1 GFP/+ cells were scarce and localized mostly in the choroid plexus, olfactory bulbs and meninges (Fig. 1a) . Moreover, the number of CCR2 RFP/+ CX3CR1 GFP/+ double-positive cells was homogenous among the sham and 1-2 days post-ischemia groups (20 ± 3 % CCR2 RFP/+ CX3CR1 GFP/+ of total CX3CR1 GFP/+ ) and increased 3-5 days after MCAo (33 ± 3 %) before significantly decreasing between 7 and 28 days after MCAo (6 ± 2 %, Fig. 1c) .
Because irradiation of the head may induce an inflammatory response [26] that may alter immune cell infiltration, CX3CR1 GFP/+
RFP/+ chimeric mice were also obtained by irradiation with head shielding (Additional file 1: Figure  S1 ). However, head shielding had no effect on brain distribution of CCR2 RFP/+ and CX3CR1 GFP/+ cells 3 and 14 days after stroke, when compared to chimeric mice without head protection (Additional file 1: Figure S1A -B). GFP/+ cells were often localized in the ischemic core and adjacent areas (95 ± 1.2 % of the total CX3CR1 GFP/+ cells), which were mainly populated by CCR2 + cells. Ramified CX3CR1 GFP/+ cells were predominant at the periphery of the lesion (85 ± 1.9 % of the total CX3CR1 GFP/+ cells) and were not seen in the core at 14 days after MCAo. Perivascular CX3CR1 GFP/+ cells were closely associated with blood vessels identified by the endothelial marker GLUT1 and were observed in both core (5 ± 1.0 %) and peri-infarct (5.8 ± 1.0 % of the total CX3CR1 GFP/+ cells) regions (Fig. 2a) . These perivascular cells exhibited elongated profiles along the major axis of the vessel or encircled the entire vessels' circumference in vascular cross sections. Similar distributions were observed 28 days after MCAo (data not shown). Head shielding did not affect the phenotype distribution of CX3CR1 GFP/+ cells (Additional file 1: Figure 1D ). In contrast, infiltrating CCR2 RFP/+ cells showed a uniform round shape without apparent processes, distinctive of amoeboid macrophages, and as described above, their distribution was limited to the ischemic core 14 days after MCAo (Fig. 2b) . Some CCR2 RFP/+ CX3CR1 GFP/+ double-positive cells showed cellular processes (Fig. 2B) , suggesting that CCR2 + cells may acquire a CX3CR1 phenotype in the tissue.
To investigate whether proliferation of brain recruited Mo/MΦ may also contribute to the increase in the number of accumulated Mo/MΦ over the time after stroke, we performed immunohistochemistry with the proliferation marker Ki67 (Fig. 3) . Some CX3CR1 GFP/+ macrophages on the brain surface were positive for Ki67 (11.3 ± 2.1 % of total CX3CR1
GFP/+ cells) 3 days after MCAo (Fig. 3a ) and 14 days after MCAo, Ki67 co-labeled with CX3CR1 GFP/+ Mo/MΦ macrophages localized either in the parenchyma or on the brain surface (Fig. 3a) . However, at this time point, the number of CX3CR1 GFP/+ Ki67 + Mo/MΦ accounted for only 1.0 ± 0.3 % of total CX3CR1 GFP/+ cells (Fig. 3b) . We did not observe CCR2 RFP/+
Ki67
+ cells (Fig. 3c) . Ki67 staining in head-shielded mice also revealed proliferation of CX3CR1 GFP/+ Mo/MΦ (Additional file 1: Figure S1C ).
CX3CR1
GFP/+ cells are phenotypically distinct from endothelial cells, smooth muscle cells, pericytes, oligodendrocytes, neurons, and astroglia
Next, we sought to determine if CX3CR1 GFP/+ cells differentiated into other cells types (Fig. 4) . CX3CR1 is expressed by BM-derived endothelial progenitor cells [27] , and BM-derived CX3CR1 + progenitors can contribute to neointimal smooth muscle cell formation [28, 29] . In addition, pericyte progenitors reside in the BM compartment from where they are mobilized after stroke [30, 31] . Therefore, considering their vascular proximity, we determined whether CX3CR1 GFP/+ cells expressed endothelial, pericyte or vascular smooth muscle cell markers. However, GLUT1 + endothelial cells, PDGFRβ + pericytes, and α-actin + smooth muscle cells, while closely associated with CX3CR1 GFP/+ cells, did not express GFP (Fig. 4a-c) . In contrast, amoeboid, ramified, and perivascular CX3CR1
GFP/+ cells were all positive for the microglia/MΦ marker Iba1 ( [16] . These studies were conducted by flow cytometry using Ly6C expression as a surrogate marker for CCR2 + and CX3CR1 + Mo/MΦ identification. Figure S4 ). NK cells and some CD8 cells also expressed RFP, as previously reported [25] , but neutrophils did not express either RFP or GFP.
In agreement with previous studies, flow cytometry of blood from CCR2 −/− mice showed reduced number of Ly6C hi cells, because CCR2 is required for egression of Ly6C hi monocytes from BM [33] . However, the number of circulating Ly6C lo monocytes was not reduced (Additional file 5: Figure S5 ). Since CCR2 is critical for the recruitment of circulating monocytes to the brain [8, 25, 34] ; p = 0.049, n = 6/group), the lack of monocyte recruitment to the brain was unlikely to be due to a reduced post-ischemic inflammatory response in CCR2 −/− mice. Fourteen days after MCAo, there was a large increase of Ly6C lo Mo/MΦ in WT mice (25 ± 12 × 10 3 cell/hemisphere), while only few Ly6C lo Mo/MΦ were observed in the brains of CCR2 −/− mice (1.6 ± 0.3 × 10 3 cell/hemisphere) (Fig. 5b) . At this point, the tissue damage measured by brain atrophy tended to be higher in CCR2 −/− (13.2 ± 3.2 mm 3 ) mice as compared to WT mice (7.7 ± 3.5 mm 3 , p = 0.2, n = 5-6/group) (Additional file 5: Figure S5) .
These results suggest that either Ly6C lo Mo/MΦ derived from infiltrating CCR2 + Ly6C hi monocytes or that parenchymal CCR2 + Ly6C hi Mo/MΦ are required for the infiltration of CX3CR1 + Ly6C lo monocytes to occur. To address this issue, we studied Mo/MΦ kinetics in mice deficient for the orphan nuclear receptor NR4A1 (Nur77). NR4A1 is essential for the generation of Ly6C lo monocytes and NR4A1 −/− mice lack circulating Ly6C lo monocytes [16] . Since NR4A1 has been implicated in neuronal function [35] , we used NR4A1 −/− chimeras lacking NR4A1 in BM-derived cells to avoid confounding effects of deletion of NR4A1 in neurons. As expected, Ly6C lo monocytes were absent in the blood of (Fig. 6a) . However, the number of brain Ly6C lo Mo/MΦ significantly increased in NR4A1 −/− BM chimeric mice 14 days after MCAo compared to the number of Ly6C lo Mo/MΦ at 3 days post-MCAo (Fig. 6b) 
Discussion
We have demonstrated that two main subsets of bloodderived macrophages accumulate in the post-ischemic brain within distinct temporal and spatial patterns. While CCR2 + Mo/MΦ spread through the ischemic lesion in the absence of CX3CR1 + Mo/MΦ at the early phase (3-5 days post-MCAo), the latter accumulated in the peri-infarct zone, encircling the lesion filled of CCR2 + Mo/MΦ at the late phase (14-28 days post-MCAo + Mo/MΦ were located in the infarct area, consistent with an active involvement in the inflammatory processes occurring in the territory most affected by ischemia. In contrast, the CX3CR1 + Mo/MΦ were mostly found at the infarct's periphery, both rostrally + Mo/MΦ with any other morphology than amoeboid suggests that the morphological polarization of Mo/MΦ is linked to CCR2 down-regulation and concomitant up-regulation of CX3CR1. Indeed, in human monocytes, CCR2 is down-regulated as the monocytes differentiate into macrophages [39] . With the exception of the necrotic center, ramified CX3CR1 + Mo/MΦ were evenly distributed throughout the infarct without any apparent regional preference. Due to their high Iba1 expression and cytoplasmic arborization, these cells were essentially indistinguishable from activated microglia. Many of CX3CR1 + Mo/ MΦ with elongated cell bodies were associated with cerebral blood vessels. These CX3CR1 + Mo/MΦ were strictly located on the abluminal side of the vessel and were also abluminal to pericytes and smooth muscle cells lining the vessel. Interestingly, CX3CR1 + Mo/MΦ did not cover all vessels uniformly but were associated with blood vessel that showed disruption of integrity as manifested by uneven or discontinuous smooth muscle cell coverage (Fig. 4c) . While we can only speculate on their function, it is possible that vessel-associated CX3CR1 + Mo/MΦ support vascular integrity by physically strengthening the wall of vessels damaged by the ischemic injury. The recent findings that monocyte depleted mice showed a higher rate of hemorrhagic transformation after ischemic stroke support this view [8] . On the other hand, vessel-associated Mo/MΦ may participate in the removal of damaged vessels to allow vascular replacement by angiogenesis. While this possibility cannot be excluded, we did not see any intracellular inclusions positive for vascular markers (e.g. GLUT1, α-actin) that would indicate a phagocytic activity of these cells. lo Mo/MΦ, exhibiting mostly a ramified phenotype, were observed at later periods. Low rates of Mo/MΦ proliferation have also been reported in a mouse model of permanent cerebral ischemia [19] . Considering these low proliferation rates, it is more likely that the increased numbers of brain Mo/MΦ are the result of continuous recruitment of hematogenous monocytes than from cell proliferation in situ. Kokovay et al. [40] also reported that recruited bone marrow-derived cells into the brain expressing microglia markers were only occasionally proliferative. Interestingly, this study described a high number of Ki67 + cells associated with blood vessels 3-14 days after ischemia and between 10 and 20 % of the Ki67 + cells were identified as BM-derived pericytes. Contrary to the Kokovay study, however, we found that these perivascular cells expressed markers of the myeloid lineage but not pericytes, a discrepancy possibly due to the use of different pericyte markers (PDGFRβ in our study vs. desmin).
On the other hand, the increase in CX3CR1 [19] . The signals and their target receptors responsible for this phenotypic shift remain to be determined.
Because CX3CR1 + Ly6C lo Mo/MΦ have been linked to post-ischemic repair in several organs including the brain [8, [41] [42] [43] , our findings have important implications for therapies targeting the migration of inflammatory leukocytes into the ischemic brain. Indeed, depletion of circulating CCR2 monocytes impairs long-term spontaneous behavioral recovery after stroke [37] , while Ly6C lo monocyte deficiency does not affect functional recovery and severity of injury after hypoxia/ischemia in mice [18] . All these findings suggest that inhibiting the recruitment of presumably proinflammatory CCR2 + Ly6C hi monocytes would also prevent the development of potentially protective CX3CR1 + Ly6C lo Mo/MΦ, which might affect repair processes during the subacute and chronic phase of ischemic brain injury. Therefore, therapies directed at interfering with monocyte recruitment into the ischemic brain must take into account the stage of evolution of the damage and the phenotype of the cells involved.
Conclusions
In conclusion, we have investigated the time course and phenotypic characteristics of monocytes recruitment into the post-ischemic brain. We found that "inflammatory" monocytes (CCR2 Mo/MΦ suggests a diversity of roles in the development and resolution of the damage. Although the molecular cues driving the phenotypic switch and its impact on tissue outcome remain to be defined, the data provide new insight into the complexities of monocyte trafficking into the brain with significant implications for immune-based approaches to ameliorate ischemic brain injury by modulating the cellular bases of post-ischemic inflammation.
